These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4559530)

  • 1. Clinical analyses of factors influencing L-dopa treatment of Parkinson's syndrome.
    Granerus AK; Steg G; Svanborg A
    Acta Med Scand; 1972; 192(1-2):1-11. PubMed ID: 4559530
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of L-dopa in Parkinson's disease.
    Godwin-Austen RB; Tomlinson EB; Frears CC; Kok HW
    Lancet; 1969 Jul; 2(7613):165-8. PubMed ID: 4183130
    [No Abstract]   [Full Text] [Related]  

  • 3. A year's experience of L-DOPA in the treatment of Parkinson's disease.
    Guidetti B; Giuffrè R
    Acta Neurochir (Wien); 1971; 24(2):81-8. PubMed ID: 5112463
    [No Abstract]   [Full Text] [Related]  

  • 4. [L-dopa in 122 cases of Parkinson's disease in patients over 70 years old. Comparative study with a group of Parkinsonian patients who are 41 to 69 years old].
    Vignalou J; Beck H
    Gerontol Clin (Basel); 1973; 15(1):50-64. PubMed ID: 4756175
    [No Abstract]   [Full Text] [Related]  

  • 5. [L-dopa effect in Parkinson's syndrome].
    Römer F; Bettag W; Bock WJ
    Z Allgemeinmed; 1971 Feb; 47(6):281-3. PubMed ID: 5571715
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Neurology; 1970 Apr; 20(4):376-7. PubMed ID: 4935022
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
    Wälzholz U
    Dtsch Med Wochenschr; 1972 Apr; 97(17):686 passim. PubMed ID: 4554502
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT
    Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056
    [No Abstract]   [Full Text] [Related]  

  • 10. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)].
    Mazza C; Buffatti PF; Bazzan A; Lion P
    Fracastoro; 1970; 63(5):768-73. PubMed ID: 5519378
    [No Abstract]   [Full Text] [Related]  

  • 11. A quantitative evaluation of the effects of L-dopa on Parkinson's disease.
    Velasco F; Velasco M
    Neuropharmacology; 1973 Feb; 12(2):89-99. PubMed ID: 4595553
    [No Abstract]   [Full Text] [Related]  

  • 12. A therapeutic paradox? Combined treatment of Parkinson's disease with levodopa and methyldopa.
    Kofman OS
    Arch Neurol; 1973 Aug; 29(2):120-1. PubMed ID: 4717719
    [No Abstract]   [Full Text] [Related]  

  • 13. L-dopa therapy in Parkinson's disease.
    Lipman IJ
    Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 15. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
    Muenter MD; Dinapoli RP; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of L-dopa in Parkinson's disease].
    Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
    Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Parkinson's syndrome with L-DOPA on an out-patient basis.
    Fehling C
    Z Neurol; 1972; 202(3):197-208. PubMed ID: 4120049
    [No Abstract]   [Full Text] [Related]  

  • 18. Sebaceous gland secretion in Parkinson's disease during L-dopa treatment.
    Kohn SR; Pochi PE; Strauss JS; Sax DS; Feldman RG; Timberlake WH
    J Invest Dermatol; 1973 Mar; 60(3):134-6. PubMed ID: 4699650
    [No Abstract]   [Full Text] [Related]  

  • 19. A double blind study of 1-dopa treatment in Parkinson's disease.
    Rinne UK; Sonninen V
    Eur Neurol; 1968; 1(3):180-91. PubMed ID: 4880674
    [No Abstract]   [Full Text] [Related]  

  • 20. [New methods for measurement of the tremor and rigidity in patients with Parkinson's disease treated with L-Dopa].
    Paci A; Freddi A; Barba C
    Riv Neurol; 1973; 43(1):15-39. PubMed ID: 4698011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.